Molecule Details
InChIKeyWBXPDJSOTKVWSJ-ZDUSSCGKSA-N
Compound NamePemetrexed
Canonical SMILESNc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)10
Pfam Stratification Cross-Family
Avg pChEMBL7.02
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00642
Drug NamePemetrexed
CAS Number137281-23-3
Groups approved investigational
ATC Codes L01BA04
DescriptionPemetrexed is a chemotherapy drug that is manufactured and marketed by Eli Lilly and Company under the brand name Alimta. It is indicated for use in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise ...

Categories: Amino Acids Amino Acids, Acidic Amino Acids, Dicarboxylic Amino Acids, Peptides, and Proteins Antimetabolites Antineoplastic Agents Antineoplastic and Immunomodulating Agents Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index Enzyme Inhibitors Folic Acid Analogues Folic Acid Antagonists Glutamates Heterocyclic Compounds, Fused-Ring Immunosuppressive Agents Myelosuppressive Agents Narrow Therapeutic Index Drugs Nucleic Acid Synthesis Inhibitors OAT3/SLC22A8 Substrates OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index
Cross-references: BindingDB: 50027656 ChEBI: 63616 CHEMBL225072 ChemSpider: 393879 Drugs Product Database (DPD): 13326 D07472 PDB: LYA PharmGKB: PA10810 PubChem:446556 PubChem:46505640 RxCUI: 68446 Therapeutic Targets Database: DCL000320 Wikipedia: Pemetrexed ZINC: ZINC000001540998
Target Activities (10)
Target Gene Organism Category Pfam pChEMBL Type Source
P00374 DHFR Homo sapiens Human PF00186 8.2 pIC50 TTD_MultiTarget
P15328 FOLR1 Homo sapiens Human PF03024 7.4 IC50 ChEMBL;BindingDB
P22102 GART Homo sapiens Human PF00586 PF02769 PF00551 PF01071 PF02843 PF02844 7.4 IC50 ChEMBL;BindingDB
P04818 TYMS Homo sapiens Human PF00303 7.2 Ki ChEMBL;BindingDB
Q96NT5 SLC46A1 Homo sapiens Human PF07690 7.1 IC50 ChEMBL;BindingDB
P14207 FOLR2 Homo sapiens Human PF03024 6.9 IC50 ChEMBL;BindingDB
P41440 SLC19A1 Homo sapiens Human PF01770 6.9 IC50 ChEMBL;BindingDB
P31939 ATIC Homo sapiens Human PF01808 PF02142 6.6 IC50 ChEMBL
Q07422 Toxoplasma gondii Pathogen PF00186 PF00303 6.4 IC50 ChEMBL;BindingDB
P00469 thyA Lacticaseibacillus casei Pathogen PF00303 6.3 Ki ChEMBL
DrugBank Target Actions (15)
Target Gene Target Name Action Type
P02768 ALB Albumin binder carriers
P27707 DCK Deoxycytidine kinase inducer enzymes
Q99808 SLC29A1 Equilibrative nucleoside transporter 1 inducer enzymes
P00374 DHFR Dihydrofolate reductase inhibitor targets
P04818 TYMS Thymidylate synthase inhibitor targets
P12461 P12461 Thymidylate synthase inhibitor targets
P22102 GART Trifunctional purine biosynthetic protein adenosine-3 inhibitor targets
P31939 ATIC Bifunctional purine biosynthesis protein ATIC inhibitor targets
O15440 O15440 ATP-binding cassette sub-family C member 5 binder transporters
Q9UNQ0 ABCG2 Broad substrate specificity ATP-binding cassette transporter ABCG2 binder transporters
P41440 SLC19A1 Reduced folate transporter substrate transporters
Q4U2R8 SLC22A6 Solute carrier family 22 member 6 substrate transporters
Q8TCC7 SLC22A8 Organic anion transporter 3 substrate transporters
Q96NT5 SLC46A1 Proton-coupled folate transporter substrate transporters
Q9NSA0 SLC22A11 Solute carrier family 22 member 11 substrate transporters